Boston Research & Management Decreased Its Cisco Systems (CSCO) Holding by $394,820 as Shares Rose; As Conatus Pharmaceuticals (CNAT) Share Value Rose, Mpm Asset Management Increased by $3.64 Million Its Holding

May 26, 2018 - By Marguerite Chambers

Cisco Systems, Inc. (NASDAQ:CSCO) Logo

Boston Research & Management Inc decreased its stake in Cisco Systems Inc. (CSCO) by 7.26% based on its latest 2017Q4 regulatory filing with the SEC. Boston Research & Management Inc sold 10,390 shares as the company’s stock rose 10.71% while stock markets declined. The institutional investor held 132,707 shares of the technology company at the end of 2017Q4, valued at $5.08M, down from 143,097 at the end of the previous reported quarter. Boston Research & Management Inc who had been investing in Cisco Systems Inc. for a number of months, seems to be less bullish one the $208.41B market cap company. The stock decreased 0.71% or $0.31 during the last trading session, reaching $43.26. About 13.73M shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 25.57% since May 26, 2017 and is uptrending. It has outperformed by 14.02% the S&P500.

Mpm Asset Management Llc increased its stake in Conatus Pharmaceuticals Inc. (CNAT) by 76.26% based on its latest 2017Q4 regulatory filing with the SEC. Mpm Asset Management Llc bought 909,091 shares as the company’s stock rose 13.83% while stock markets declined. The institutional investor held 2.10 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $9.71M, up from 1.19 million at the end of the previous reported quarter. Mpm Asset Management Llc who had been investing in Conatus Pharmaceuticals Inc. for a number of months, seems to be bullish on the $111.24M market cap company. The stock increased 0.82% or $0.03 during the last trading session, reaching $3.7. About 261,626 shares traded. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has risen 12.92% since May 26, 2017 and is uptrending. It has outperformed by 1.37% the S&P500.

Among 7 analysts covering Conatus Pharma (NASDAQ:CNAT), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Conatus Pharma had 17 analyst reports since September 22, 2015 according to SRatingsIntel. On Thursday, March 1 the stock rating was initiated by Oppenheimer with “Buy”. Stifel Nicolaus maintained it with “Buy” rating and $7 target in Tuesday, December 20 report. H.C. Wainwright initiated Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) on Tuesday, September 22 with “Buy” rating. Oppenheimer maintained Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) on Thursday, May 3 with “Buy” rating. The firm has “Buy” rating by Oppenheimer given on Thursday, March 22. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, August 3. The rating was maintained by Oppenheimer on Wednesday, March 7 with “Buy”. The company was maintained on Wednesday, November 9 by Stifel Nicolaus. The firm has “Buy” rating given on Tuesday, December 20 by H.C. Wainwright. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, November 5.

Investors sentiment decreased to 1.1 in Q4 2017. Its down 0.73, from 1.83 in 2017Q3. It turned negative, as 14 investors sold CNAT shares while 17 reduced holdings. 11 funds opened positions while 23 raised stakes. 11.71 million shares or 7.58% more from 10.89 million shares in 2017Q3 were reported. Reilly Advisors Limited Liability holds 0.01% or 22,011 shares. Utd Capital Fincl Advisers Ltd stated it has 314,955 shares or 0.01% of all its holdings. 215,843 were accumulated by National Bank & Trust Of Mellon. Northern Trust Corporation holds 0% or 285,401 shares. Tci Wealth Advsr Inc owns 10 shares or 0% of their US portfolio. New York State Common Retirement Fund accumulated 24,100 shares. Fin Architects, New Jersey-based fund reported 1,600 shares. Goldman Sachs Grp reported 73,751 shares. Geode Cap Mngmt Lc has 429,556 shares for 0% of their portfolio. Schwab Charles Inv Management holds 180,556 shares. Alliancebernstein Limited Partnership invested in 10,800 shares or 0% of the stock. Denver Advisors Limited Liability Company holds 0% or 10,715 shares. Royal Natl Bank Of Canada stated it has 1,143 shares. 2.10 million are owned by Mpm Asset Management Ltd Limited Liability Company. Balyasny Asset Mgmt Lc holds 29,727 shares or 0% of its portfolio.

Another recent and important Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) news was published by Seekingalpha.com which published an article titled: “Conatus Pharmaceuticals: Down But Certainly Not Out” on April 28, 2018.

More notable recent Cisco Systems, Inc. (NASDAQ:CSCO) news were published by: Seekingalpha.com which released: “Cisco Systems: Should We Be Worried?” on May 21, 2018, also Globenewswire.com with their article: “Oppenheimer and Cisco to Host Tech Talk on Cisco’s AppDynamics” published on May 23, 2018, 247Wallst.com published: “Cisco Still Holds Rank as Top Performing Dow Stock” on May 05, 2018. More interesting news about Cisco Systems, Inc. (NASDAQ:CSCO) were released by: 247Wallst.com and their article: “Cisco Systems Remains Top-Performing Dow Stock” published on May 12, 2018 as well as Nasdaq.com‘s news article titled: “Why the Dow Jones May Struggle to Stay Above Water” with publication date: May 25, 2018.

Among 39 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 29 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Cisco Systems Inc. had 170 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Thursday, August 13. On Wednesday, October 14 the stock rating was initiated by Barclays Capital with “Overweight”. The firm earned “Buy” rating on Wednesday, September 14 by Deutsche Bank. The rating was maintained by JP Morgan on Thursday, May 19 with “Neutral”. The firm has “Buy” rating by Argus Research given on Friday, August 19. The rating was downgraded by BMO Capital Markets on Tuesday, May 9 to “Market Perform”. The rating was maintained by Wells Fargo on Thursday, February 15 with “Buy”. As per Friday, October 6, the company rating was maintained by Jefferies. Robert W. Baird maintained Cisco Systems, Inc. (NASDAQ:CSCO) on Monday, August 7 with “Buy” rating. The rating was maintained by Credit Suisse on Thursday, August 18 with “Underperform”.

Boston Research & Management Inc, which manages about $265.07M and $199.42 million US Long portfolio, upped its stake in Ishares Core S&P 500 Etf (IVV) by 2,224 shares to 15,380 shares, valued at $4.13 million in 2017Q4, according to the filing.

Cisco Systems, Inc. (NASDAQ:CSCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>